Trial intelligence / Profile preview

MOTHER: Buprenorphine vs Methadone in Pregnant Women

NCT00271219Phase 3Completed

Sponsor
Johns Hopkins University
Start
Jul 2005
Primary completion
Aug 2009
Countries
3
01

Overview

Phase 3, randomised, double-blind trial of buprenorphine in opioid use disorder (OUD), sponsored by Johns Hopkins University. Primary endpoints: Child's Head Circumference Measurement and Child's Length of Hospital Stay. Started Jul 2005; status: completed.

02

Drugs

buprenorphine
03

Conditions

opioid use disorder (OUD)

Beyond the preview

Go deeper on NCT00271219.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00271219.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call